EN DE
Watch Maxnerva Technology Services Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Maxnerva Technology Services Ltd (1037) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Maxnerva Technology Services Ltd stock HK$0.62, price HK$0.61, upside +2.5%, quality 62 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology HK · ISIN BMG5993Y1066

MT Maxnerva Technology Services Ltd logo Thin data Nov 10, 2026

Maxnerva Technology Services Ltd

1037 · HK

Solid company, but the stock is already about fairly priced and price moving sideways: meets 1 of 3 rules.

Get notified free when this changes
Quality 62/100 
Low debt 
Fair value HK$0.6201 · Fairly valued 
Price moving sideways (no uptrend) 
Mixed vs. peers (6/12) 
Weak Growth (revenue 3y −5.3 %/yr in CNY) 
Loss-making · -0.5% net margin (TTM) 
Negative free cash flow 
Narrow moat 16/100
Thin data 
Estimate
Watch Maxnerva Technology Services Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$1.26 HK$0.1460 Fair Value HK$0.6201 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range HK$0.1460 – HK$1.26 · fair‑value band HK$0.4651 – HK$0.7751 · the HK$0.6050 price screens below the HK$0.6201 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Maxnerva Technology Services in your weekly email

Every Wednesday you see whether Maxnerva Technology Services is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Maxnerva Technology Services Limited, an investment holding company, operates in the digital industry and digital life businesses in the People's Republic of China, Taiwan, Vietnam, the Americas, Europe, and internationally.

Show moreShow less

It engages in the provision of smart manufacturing solutions and services, including the implementation of a combination of software systems, such as enterprise resources planning, manufacturing execution system, product lifecycle management system, and warehouse management system, as well as automation equipment; the implementation of facility monitors and control systems for monitoring the efficiency of the usage of water, power, and gas at production plants; and the implementation of facial recognition systems for labor and security management of the industrial parks.

The company is also involved in the sourcing and distribution of branded smart office equipment solutions; testing and inspection services for new and existing electronic products; and provision of digital retail signage, IT operating and post-installation maintenance services, and temperature screening access control solutions.

Maxnerva Technology Services Limited was incorporated in 1994 and is based in Tsim Sha Tsui, Hong Kong.

Stock analysis

Maxnerva Technology Services Ltd (1037) currently trades at HK$0.6050, while our estimate is HK$0.6201, so the stock looks roughly fairly valued today (gap 2.4%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$0.4651 (bear) to HK$0.7751 (bull), the price of HK$0.6050 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 62/100 (solid quality), in the Technology sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Maxnerva Technology Services Ltd reported revenue of 708M CNY in FY2025 versus 596M CNY in FY2021, a compound +4.4%/yr. Reported net income was −14.6M CNY in FY2025.

Key figures

Market cap HK$427M (≈ $54.5M) Micro · P/S ratio 0.62 · Net margin −0.5% · Return on equity −0.8% · Return on assets (EBIT) 1.0% (5-year average) · Operating margin 2.5% · Revenue (TTM) 702M CNY · Revenue growth (YoY) −1.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 16 out of 100 (medium confidence).

What moves the price

The share trades about 23% below its 52-week high and 55% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Technology peers we cover trades at 24% fair-value upside, at 3%, 1037 screens richer than that median.

Fair Value

Bear HK$0.4651 Fair Value HK$0.6201 Bull HK$0.7751
Price HK$0.6050 · Upside +2.5%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 62/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 28
How much profit the company makes from its sales and capital
Quality Growth 70
Are margins and returns getting better?
Cashflow 33
Do the profits arrive as real cash?
Financial strength 90
Debt, balance sheet and risk of trouble
Investment 99
Does it invest with discipline instead of growing at any price?
Low Volatility 30
How calm the share price moves, does not count
Price momentum 33
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 38
Distance to the 52-week high, does not count
New shares 78
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 18/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+26.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.2%
Start year 2020 (pandemic)
Revenue growth 27 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
4.0% (2020) → −1.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch 1037, get fair value alerts →

Compare Maxnerva Technology Services Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 517 stocks

Beats the industry median on 6/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 62 · Above median
Fair Value upside +2.5% · Above median
Profitability
Return on assets −2.5% · Bottom 25%
Net margin (12 months) −0.5% · Below median
Operating margin (12 months) 2.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) −1.7% · Below median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Information Technology Services median · lower = cheaper

P/B 0.90× · Cheapest 25%
P/S (12 months) 0.52× · Cheapest 25%
EV/EBITDA 10.7× · Pricier than median
PEG 0.64× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)37 · sector 33
FUTURE (revenue growth)0 · sector 30
PAST (return on equity)0 · sector 31
HEALTH (low debt)99 · sector 97
DIVIDEND (yield)0 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Information Technology Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Cognizant Technology Solutions Corporation CTSH $63.01 $139.68 +122% vs 1037
Wipro Limited WIPRO ₹194.60 ₹287.86 +48% vs 1037
Infosys Limited INFY ₹1,142 ₹1,661 +46% vs 1037
Accenture plc ACN $250.49 $332.90 +33% vs 1037
Tata Consultancy Services Limited TCS ₹2,408 ₹2,993 +24% vs 1037
HCL Technologies Limited HCLTECH ₹1,378 ₹1,602 +16% vs 1037
Amadeus IT Group AMS €62.16 €68.53 +10% vs 1037
CDW Corporation CDW $171.65 $165.54 −4% vs 1037
Broadridge Financial Solutions, Inc BR $192.45 $161.18 −16% vs 1037
International Business Machines Corporation IBM $247.13 $185.39 −25% vs 1037

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Maxnerva Technology Services Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Maxnerva Technology Services Ltd Fair Value". https://www.fairvalue-calculator.com/stock/1037

Frequently asked questions

Is Maxnerva Technology Services Ltd (1037) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is HK$0.6201 versus a price of HK$0.6050, about +3% upside (fairly valued).
What is the fair value of 1037?
Our estimate for Maxnerva Technology Services Ltd is HK$0.6201 (as of Nov 10, 2026), built from audited fundamentals. The current price: HK$0.6050.
What is the quality score of 1037?
Maxnerva Technology Services Ltd has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Maxnerva Technology Services Ltd (1037)?
Our calculated price target is the estimate of HK$0.6201 (as of Nov 10, 2026). Cautious scenario HK$0.4651, optimistic scenario HK$0.7751. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Maxnerva Technology Services Ltd stock forecast for 2026?
Our estimate puts fair value at HK$0.6201, about +3% upside versus a price of HK$0.6050 (fairly valued). Cautious scenario HK$0.4651, optimistic scenario HK$0.7751. The calculation is refreshed regularly with new filings.
What is the revenue of Maxnerva Technology Services Ltd (1037)?
Maxnerva Technology Services Ltd reported trailing-twelve-month revenue of about 702M CNY (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Maxnerva Technology Services Ltd (1037)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Maxnerva Technology Services Ltd it is HK$0.6201 per share (as of Nov 10, 2026), against a price of HK$0.6050.
Is Maxnerva Technology Services Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 1037 trades below its calculated fair value: price HK$0.6050, fair value HK$0.6201, a gap of about +3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1037?
No. The price is what the market pays today (HK$0.6050); the fair value is what the company's own numbers justify (HK$0.6201). For Maxnerva Technology Services Ltd the two are HK$0.0151 per share apart. That gap is exactly why we show both numbers side by side.
How much is Maxnerva Technology Services Ltd worth?
The market values Maxnerva Technology Services Ltd at about HK$427M (market capitalisation, as of Nov 10, 2026). Per share that is HK$0.6050; our models calculate a fair value of HK$0.6201 per share.
What do the bullish and bearish scenarios say about 1037?
Our models span a range for Maxnerva Technology Services Ltd: cautious scenario HK$0.4651, base HK$0.6201, optimistic HK$0.7751 per share (as of Nov 10, 2026, price HK$0.6050). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of 1037?
The PEG ratio of Maxnerva Technology Services Ltd is 0.64 (P/E divided by earnings growth, as of Nov 10, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Maxnerva Technology Services Ltd (1037)?
Balance-sheet figures for Maxnerva Technology Services Ltd (as of Nov 10, 2026): return on equity −0.8%, debt of 0.03 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is 1037 from its 52-week high?
Maxnerva Technology Services Ltd trades at HK$0.6050, about 23% below its 52-week high of HK$0.7900 and 55% above the low of HK$0.3900 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.6201 is for.
Which stocks are comparable to Maxnerva Technology Services Ltd?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Maxnerva Technology Services Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price HK$0.6050, calculated fair value HK$0.6201 (+3%), Quality Score 62/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1% above its aggregate fair value. Maxnerva Technology Services Ltd currently trades 2% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Maxnerva Technology Services Ltd (1037)?
The closing price on Nov 13, 2026 was HK$0.6050. Our estimate is HK$0.6201, about +3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Maxnerva Technology Services Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Maxnerva Technology Services Ltd

How large is the market capitalisation of Maxnerva Technology Services Ltd (1037)?
The market capitalisation of Maxnerva Technology Services Ltd is HK$427M (≈ $54.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Maxnerva Technology Services Ltd (1037)?
The price-to-sales ratio of Maxnerva Technology Services Ltd is 0.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Maxnerva Technology Services Ltd (1037)?
The net margin of Maxnerva Technology Services Ltd is −0.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Maxnerva Technology Services Ltd (1037)?
The return on equity (ROE) of Maxnerva Technology Services Ltd is −0.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Maxnerva Technology Services Ltd (1037)?
On an EBIT basis the return on assets of Maxnerva Technology Services Ltd is 1.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Maxnerva Technology Services Ltd (1037)?
The operating margin of Maxnerva Technology Services Ltd is 2.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Maxnerva Technology Services Ltd (1037)?
Revenue at Maxnerva Technology Services Ltd is down 1.7% versus a year earlier (3y avg −5.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Maxnerva Technology Services Ltd (1037)?
Earnings per share at Maxnerva Technology Services Ltd are down 10.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Maxnerva Technology Services Ltd (1037) generate?
The free cash flow of Maxnerva Technology Services Ltd is −67.1M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Maxnerva Technology Services Ltd (1037) hold?
Maxnerva Technology Services Ltd holds more cash than debt, 104M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Maxnerva Technology Services Ltd in the live analysis

One click puts Maxnerva Technology Services Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.